Trial intelligence / Profile preview

Socheongryong-tang and Yeongyopaedok-san for Upper Respiratory Tract Infection

NCT01019889Phase 3Completed

Sponsor
Korea Health Industry Development Institute
Start
Sep 2008
Primary completion
Jun 2009
Modality
Small Molecules
01

Overview

Phase 3, randomised, double-blind trial in upper respiratory tract infection (URI) comparing SCRT, YPS and Placebo (3 arms). Primary endpoint: Wisconsin Upper Respiratory Symptom Survey - Korean version Score. Started Sep 2008; status: completed.

02

Drugs

so-cheong-ryong-tangyeongyopaedok-san
03

Conditions

upper respiratory tract infection (URI)

Beyond the preview

Go deeper on NCT01019889.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01019889.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call